pyrroles has been researched along with Argentaffinoma in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Adhoum, N; Catak, D; Moncer, F; Monser, L | 1 |
| Carley, W; DePrimo, SE; Harmon, CS; Heymach, JV; Huang, X; Khajavi, M; Kulke, MH; Lenz, HJ; Lin, E; Meropol, NJ; Tye, L; Wang, X; Wu, HK; Zurita, AJ | 1 |
| Baum, CM; Bergsland, E; Fuchs, CS; Huang, X; Kulke, MH; Lenz, HJ; Li, JZ; Meropol, NJ; Picus, J; Posey, J; Ryan, DP; Stuart, K; Tye, L | 1 |
| Feng, CC; Kao, WY; Lin, HF; Lu, CC; Yu, CY | 1 |
| Faivre, S; Hammel, P; Raymond, E; Ruszniewski, P | 1 |
| Buti, S; Buttitta, F; Calabrese, F; Cavazza, A; Di Chiara, F; Felicioni, L; Garagnani, L; Marchetti, A; Mengoli, MC; Migaldi, M; Nannini, N; Nicoli, D; Rea, F; Rossi, G; Sartori, G; Schirosi, L; Valli, R | 1 |
| Reidy-Lagunes, D; Thornton, R | 1 |
| Dham, A; Dudek, AZ; Truskinovsky, AM | 1 |
| Berg, BC; Chow, S; Suwattee, P; Warshaw, EM | 1 |
| Kidd, M; Malfertheiner, MV; Modlin, IM; Pfragner, R; Schally, AV | 1 |
| Schein, PS | 1 |
2 review(s) available for pyrroles and Argentaffinoma
| Article | Year |
|---|---|
Pancreatic neuroendocrine and carcinoid tumors: what's new, what's old, and what's different?
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Carcinoid Tumor; Combined Modality Therapy; Dacarbazine; Embolization, Therapeutic; Everolimus; Humans; Immunosuppressive Agents; Indoles; Neuroendocrine Tumors; Pancreatic Neoplasms; Pyrroles; Sirolimus; Streptozocin; Sunitinib; Temozolomide; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factors; Yttrium Radioisotopes | 2012 |
Chemotherapeutic management of the hormone-secreting endocrine malignancies.
Topics: Adenoma, Islet Cell; Adrenal Gland Neoplasms; Aminoglutethimide; Aniline Compounds; Antibiotics, Antineoplastic; Antineoplastic Agents; Butanones; Carcinoid Tumor; Diazoxide; Humans; Hypoglycemia; Insulin Antagonists; Kidney Tubules; Metyrapone; Mitotane; Neoplasm Metastasis; Pheochromocytoma; Pyrimidines; Pyrroles; Pyrrolidines; Ribonucleosides; Serotonin Antagonists; Streptozocin | 1972 |
2 trial(s) available for pyrroles and Argentaffinoma
| Article | Year |
|---|---|
Circulating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumours.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Carcinoid Tumor; Cytokines; Disease-Free Survival; Female; Humans; Indoles; Leukocyte Count; Monocytes; Neuroendocrine Tumors; Pyrroles; Sunitinib; Treatment Outcome | 2015 |
Activity of sunitinib in patients with advanced neuroendocrine tumors.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoid Tumor; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Immunohistochemistry; Indoles; Male; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Pancreatic Neoplasms; Pyrroles; Quality of Life; Risk Assessment; Single-Blind Method; Sunitinib; Survival Analysis; Treatment Outcome | 2008 |
7 other study(ies) available for pyrroles and Argentaffinoma
| Article | Year |
|---|---|
Electrochemical sensor based on MIP for highly sensitive detection of 5-hydroxyindole-3-acetic acid carcinoid cancer biomarker in human biological fluids.
Topics: Acetates; Biomarkers, Tumor; Carcinoid Tumor; Electrochemical Techniques; Electrodes; Humans; Hydroxyindoleacetic Acid; Indoles; Limit of Detection; Molecular Imprinting; Polymers; Pyrroles | 2021 |
Sunitinib malate as the salvage therapy in advanced rectal carcinoid tumor.
Topics: Antineoplastic Agents; Carcinoid Tumor; Humans; Indoles; Male; Middle Aged; Pyrroles; Rectal Neoplasms; Salvage Therapy; Sunitinib | 2008 |
Sunitinib paves the way for targeted therapies in neuroendocrine tumors.
Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoid Tumor; Cell Line, Tumor; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; ErbB Receptors; Humans; Indoles; Kidney Neoplasms; Lung Neoplasms; Melphalan; Neovascularization, Pathologic; Neuroendocrine Tumors; Pancreatic Neoplasms; Procarbazine; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrroles; Sunitinib; Vinblastine; Xenograft Model Antitumor Assays | 2009 |
Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Benzenesulfonates; Carcinoid Tumor; Carcinoma, Squamous Cell; CD5 Antigens; DNA Mutational Analysis; Enzyme Activation; Female; Genetic Association Studies; Humans; Imatinib Mesylate; Indoles; Male; Middle Aged; Mutation, Missense; Niacinamide; Phenylurea Compounds; Piperazines; Proto-Oncogene Proteins c-kit; Pyridines; Pyrimidines; Pyrroles; Retrospective Studies; Sorafenib; Sunitinib; Thymoma; Thymus Neoplasms; Transcription Factors; Treatment Outcome; Tumor Suppressor Proteins | 2012 |
Thymic carcinoid responds to neoadjuvant therapy with sunitinib and octreotide: a case report.
Topics: Adult; Antineoplastic Agents, Hormonal; Biopsy, Needle; Carcinoid Tumor; Follow-Up Studies; Humans; Indoles; Ki-67 Antigen; Lymphatic Diseases; Male; Necrosis; Neoplasm Staging; Octreotide; Pneumonectomy; Positron-Emission Tomography; Proto-Oncogene Proteins c-kit; Pyrroles; Radiography, Thoracic; Sunitinib; Synaptophysin; Thymus Neoplasms; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Sunitinib: a cause of bullous palmoplantar erythrodysesthesia, periungual erythema, and mucositis.
Topics: Antineoplastic Agents; Carcinoid Tumor; Drug Eruptions; Erythema; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Immunosuppressive Agents; Indoles; Male; Middle Aged; Mouth Mucosa; Mucositis; Pyrroles; Risk Assessment; Skin Diseases, Vesiculobullous; Sunitinib; Treatment Outcome | 2008 |
Inhibition of proliferation of small intestinal and bronchopulmonary neuroendocrine cell lines by using peptide analogs targeting receptors.
Topics: Apoptosis; Bronchial Neoplasms; Carcinoid Tumor; Caspase 3; Cell Cycle; Cell Proliferation; Cytotoxins; Doxorubicin; Flow Cytometry; Gonadotropin-Releasing Hormone; Growth Hormone-Releasing Hormone; Humans; Intestinal Neoplasms; Intestine, Small; Ki-67 Antigen; Lung Neoplasms; Pyrroles; Receptors, LHRH; Receptors, Somatostatin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured | 2008 |